Morgan Stanley’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $716K | Buy |
29,827
+3,448
| +13% | +$89.9K | ﹤0.01% | 5302 |
|
|
2025
Q4 | $554K | Buy |
26,379
+17,658
| +202% | +$186K | ﹤0.01% | 5453 |
|
|
2025
Q3 | $86.8K | Sell |
8,721
-3,045
| -26% | -$34.4K | ﹤0.01% | 6216 |
|
|
2025
Q2 | $107K | Buy |
11,766
+2,219
| +23% | +$21.1K | ﹤0.01% | 6104 |
|
|
2025
Q1 | $91.1K | Sell |
9,547
-4,227
| -31% | -$51.3K | ﹤0.01% | 6055 |
|
|
2024
Q4 | $155K | Sell |
13,774
-3,257
| -19% | -$43.6K | ﹤0.01% | 5877 |
|
|
2024
Q3 | $245K | Buy |
17,031
+9,978
| +141% | +$148K | ﹤0.01% | 5678 |
|
|
2024
Q2 | $122K | Buy |
7,053
+823
| +13% | +$12K | ﹤0.01% | 5891 |
|
|
2024
Q1 | $124K | Buy |
6,230
+5,670
| +1,013% | +$69.9K | ﹤0.01% | 5905 |
|
|
2023
Q4 | $5.89K | Buy |
560
+280
| +100% | +$2.81K | ﹤0.01% | 6965 |
|
|
2023
Q3 | $2.48K | Sell |
280
-477
| -63% | -$4.48K | ﹤0.01% | 7082 |
|
|
2023
Q2 | $7.3K | Sell |
757
-6,366
| -89% | -$71.2K | ﹤0.01% | 6904 |
|
|
2023
Q1 | $98.2K | Sell |
7,123
-1,600
| -18% | -$25.4K | ﹤0.01% | 6008 |
|
|
2022
Q4 | $133K | Sell |
8,723
-26,512
| -75% | -$304K | ﹤0.01% | 5855 |
|
|
2022
Q3 | $321K | Sell |
35,235
-37,955
| -52% | -$351K | ﹤0.01% | 5493 |
|
|
2022
Q2 | $619K | Buy |
73,190
+51,483
| +237% | +$590K | ﹤0.01% | 5314 |
|
|
2022
Q1 | $426K | Sell |
21,707
-14,451
| -40% | -$292K | ﹤0.01% | 5508 |
|
|
2021
Q4 | $879K | Buy |
36,158
+35,461
| +5,088% | +$1.19M | ﹤0.01% | 5165 |
|
|
2021
Q3 | $27K | Sell |
697
-7,704
| -92% | -$322K | ﹤0.01% | 6977 |
|
|
2021
Q2 | $378K | Buy |
8,401
+3,779
| +82% | +$143K | ﹤0.01% | 5694 |
|
|
2021
Q1 | $158K | Buy |
4,622
+819
| +22% | +$27.9K | ﹤0.01% | 5788 |
|
|
2020
Q4 | $138K | Buy |
+3,803
| New | +$55.5K | ﹤0.01% | 5775 |
|
Other funds holding GLSI
VCM
N
VPM
VFT
